CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...